Abbott Laboratories (ABT) Stock: Revenue, Earnings, Margins & Valuation
Abbott Laboratories (ABT), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Abbott Laboratories key figures (FY 2025)
| Revenue | 44.33 USD bn |
|---|---|
| Net income | 6.74 USD bn |
| Net margin | 15.2 % |
Abbott Laboratories revenue by segment
| Established Pharmaceutical Products | 5.54 USD bn |
|---|---|
| Nutritional Products | 8.45 USD bn |
| Diagnostic Products | 8.94 USD bn |
| Medical Devices | 21.39 USD bn |
Abbott Laboratories business model
The income statement of Abbott Laboratories is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.